小黃鴨德盈(02250.HK)曾飆33%創逾一年高 或獲沙地基金參投
小黃鴨德盈(02250.HK)今日(4日)高開14.9%報1.62元後,初段升幅擴大,曾升逾33%,最高見1.88元創逾一年高。現報1.72元,升近22%,成交112.8萬股,涉資192.49萬元。
小黃鴨德盈隔晚(3日)公布,與公共投資基金簽訂備忘錄,擬與沙地阿拉伯公共投資基金(PIF)亞洲分部以投資、項目和品牌發展等形式進行合作,預計總投資額2.5億美元,項目預計由PIF全額出資。
根據備忘錄,PIF可通過可換股證券的方式向公司提供為期五年的融資;投資公司拓展海外娛樂及旅遊項目,包括聯合開發B.Duck 娛樂公園及酒店;並擔任B.Duck IP在中東地區的品牌代理。備忘錄不具法律約束力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.